CHNXF Stock Price, Chart, Stats & News

ChitogenX Inc.
Save
ChitogenX Inc. (CHNXF) does not currently pay a dividend.
627,628
Market cap
–
Current P/E
–
Forward P/E
CHNXF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
ChitogenX Inc. is a biologics firm focused on orthopedic and sports medicine, committing its efforts to pioneering novel soft tissue repair technologies. The company's primary objective is to elevate the efficacy of sports medicine surgical procedures through its research and development. Its developmental pipeline includes a range of specialized products: Ortho-R, a specific formulation designed for rotator cuff injuries; Ortho-M, a biopolymer addressing meniscus repair; Ortho-C, another biopolymer for the regeneration of articular cartilage; and Ortho-V, a biopolymer developed to facilitate the healing of osteoarthritis.
Similar securities
Based on sector and market capitalization
Report issue





